Nerve growth factor enhances survival and cytotoxic activity of human eosinophils

British Journal of Haematology

Volumn 93, Issue 2, 1996, Pages 299-302

  Hamada, Atsuo ^a   Watanabe, Naohiro ^a   Ohtomo, Hiroshi ^a   Matsuda, Hiroshi ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

cytotoxic activity; eosinophils; IL 5; nerve growth factor; phenotypic change

Indexed keywords

NERVE GROWTH FACTOR; RECOMBINANT INTERLEUKIN 5;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; EOSINOPHIL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0029922081     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.5151055.x     Document Type: Article

References (21)

1. Aloe, L., Alleva, E., Bohm, A. & Levi-Montalcini. R. (1986) Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proceedings of the National Academy of Sciences of the United States of America, 83, 6184-6187.
2. Bandtlow, C.E., Heumann, R., Schwab, M.E. & Thoenen, H. (1987) Cellular localization of nerve growth factor synthesis by in situ hybridization. EMBO Journal, 6, 891-899.
3. Bass, D.A. & Szejada, P. (1979) Eosinophils versus neutrophils in host defense: killing of newborn larvae of Trichinella spiralis by human granulocytes in vitro. Journal of Clinical Investigation, 64, 1415-1422.
4. Fukuda, T. & Gleich, G.J. (1989) Heterogeneity of human eosinophils. Journal of Allergy and Clinical Immunology, 83, 369-372.
5. Hamada, A. & Greene, B.M. (1987) Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro. Journal of Immunology, 138, 1240-1245.
6. Hamada, A., Watanabe, N. & Kobayashi, A. (1992) Occurrence and characteristics of hypodense eosinophils in rats infected with Trichinella spiralis. Parasite Immunology, 14, 503-512.
7. Kaiman, Y., Ushio, H., Koyama, H., Okada, M., Oikawa, M., Yoshihara, T., Kaneko, M. & Matsuda, H. (1991) 2.58 nerve growth factor enhances the survival, phagocytosis, and superoxide production of murine neutrophils. Blood, 77, 1320-1325.
8. Koroly, M.J. & Young, M. (1981) Nerve growth factor. Handbook of Experimental Pharmacology, 57, 249-276.
9. Levi-Montalcini, R. & Angeletti, P.U. (1963) Essential role of the nerve growth factor on the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Developmental Biology, 7, 653-659.
10. Litt, M. (1963) Studies in experimental eosinophilia. V. Eosinophils in lymphnodes of guinea pigs following primary antigenic stimulation. American Journal of Pathology, 42, 529-549.
11. Matsuda, H., Coughlin, M.D., Bienenstock, J. & Denburg, J.A. (1988) Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proceedings of the National Academy of Sciences of the United States of America, 85, 6508-6512.
12. Matsuda, H., Kannan, Y., Ushio, H., Kiso, Y., Kanemoto, T., Suzuki, H. & Kitamura, Y. (1991) Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. Journal of Experimental Medicine, 174, 7-14.
13. Oger, J., Arnason, B.G.W., Pantazis, N.J., Lehrich, J. & Young, M. (1974) Synthesis of nerve growth factor by L and 3T3 cells in culture. Proceedings of the National Academy of Sciences of the United States of America, 71, 1554-1558.
14. Otten, U., Ehrhard, P. & Peck, P. (1989) Nerve growth factor induces growth and differentiation of human B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 86, 10059-10063.
15. Owen, W.F., Jr. Rothenberg, M.F., Silberstein, D.S., Gasson, J.C., Stevens, R.L., Austen, K.F. & Soberman. R.J. (1987) Regulation of human eosinophil viability, density, and function by granulocyte/ macrophage colony-stimulating factors in the presence of 3T3 fibroblasts. Journal of Experimental Medicine, 166, 129-141.
16. Owhashi, M. & Ishii, A. (1982) Purification and characterization of a high molecular weight eosinophil chemotactic factor from Schistosoma japonicum eggs. Journal of Immunology, 129, 2226-2231.
17. Rothenberg, M.E., Owen, W.F., Jr. Silberstein, D.S., Woods, J., Soberman, R.J., Austen, K.F. & Stevens, R.L. (1988) Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. Journal of Clinical Investigation, 81, 1986-1992.
18. Rothenberg, M.E., Peterson, J., Stevens, R.L., Silberstein, D.S., McKenzie, D.T., Austen, K.F. & Owen W.F., Jr (1989) IL-5 dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody dependent cytotoxicity. Journal of Immunology, 143, 2311-2316.
19. Thoenen, H. & Edgar, D. (1985) Neurotrophic factors. Science, 229, 238-242.
20. Weller, P.F. & Goetzl, E.J. (1979) The regulatory and effector roles of eosinophils. Advances in Immunology, 27, 339-371.
21. Young, M., Oger, J., Blanchard, M.H., Asdourian, H., Amos, H. & Arnason, B.G.W. (1975) Secretion of a nerve growth factor by primary chick fibroblast cultures. Science, 187, 361-362.